DUBLIN--(BUSINESS WIRE)--The "Global Scleroderma Therapeutics Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. The value of the global scleroderma ...

NEW YORK, April 21, 2022 (GLOBE NEWSWIRE) -- In 2021, the systemic scleroderma treatment market was valued at nearly US$ 749.4 Mn, and is estimated to expand at a CAGR of 8% over the forecast period ...

DEAR MAYO CLINIC: I’m a 50-year-old woman recently diagnosed with scleroderma. What causes it, and can anything stop its progression? What medications are available, and at what point should I begin ...

DEAR MAYO CLINIC: I’m a 50-year-old woman recently diagnosed with scleroderma. What causes it, and can anything stop its progression? What medications are available, and at what point should I begin ...

Researchers found a unique immune cell plays a key role in the chronic inflammation and scarring in the lungs and skin of people with scleroderma, or systemic sclerosis. After injecting mice with ...

Dublin, Feb. 26, 2021 (GLOBE NEWSWIRE) -- The "Systemic Scleroderma Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class; By Regions; Segment Forecast, 2021-2028" report has ...

Investigators have identified a drug that is currently approved to treat certain types of cancer, Gleevec, that could provide the first treatment for scleroderma, a chronic connective tissue disease ...

Scleroderma is not curable it can be considerably controlled with treatment methods that are aimed at the various symptoms that ravage the patient’s body. In some patients, the treatment could be ...

Scleroderma is an intricate autoimmune disease wherein one notices the hardening and tightening of the skin and connective tissues. Here, the immune system causes inflammation and injury to the cells ...

A chronic autoimmune disease of the skin, called scleroderma, is not contagious or infectious and often not harmful. However, when this connective tissue disorder involves any internal organs, it can ...

Report Ocean presents a new report on Systemic scleroderma treatment market size, share, growth, industry trends, and forecast 2030, covering various industry elements and growth trends helpful for ...

Bosentan has been approved for the treatment of pulmonary arterial hypertension (PAH); however, no extensive analysis of the effect of bosentan on the subset of patients with PAH associated with ...